Aeterna Zentaris

Weeks after launching Aeterna Zentaris castoff, Strongbridge turns around and sells rights to Novo Nordisk — at a premium
Endpoints
Wed, 10/31/18 - 11:47 am
Strongbridge
Aeterna Zentaris
Macrilen
Novo Nordisk
adult growth hormone deficiency
Post-review, Aeterna Zentaris strikes commercialization deal
Biopharma Dive
Thu, 01/18/18 - 11:29 am
Aeterna Zentaris
Macrilen
Here's Why AEterna Zentaris Is Soaring Today
Insider Financial
Fri, 12/22/17 - 09:49 am
Aeterna Zentaris
Macrilen
adult growth hormone deficiency
AGHD
Warring with ex-CEO, options shrinking, Aeterna Zentaris turns to a strategic review
Endpoints
Wed, 08/9/17 - 09:31 am
Aeterna Zentaris
David Dodd
Macrilen
Aeterna Zentaris claims it booted CEO and then discovered a plot to grab control of its lead asset
Endpoints
Sat, 08/5/17 - 10:32 pm
Aeterna Zentaris
Pharma CEOs
Macrilen
David Dodd
Aeterna Zentaris taps new CEO as it evaluates alternatives
BioPharma Dive
Mon, 07/24/17 - 11:03 am
Aeterna Zentaris
Pharma CEOs
Macrilen
Endometrial Cancer Drug Fails in Late-Stage Clinical Trial
Xtalks
Fri, 05/5/17 - 10:25 am
endometrial cancer
Aeterna Zentaris
clinical trials
Zoptrex
Aeterna Zentaris shares eviscerated by its latest late-stage drug disaster
Endpoints
Mon, 05/1/17 - 10:54 am
Aeterna Zentaris
clinical trials
Zoptrex
endometrial cancer
Aeterna Zentaris doubles down on macimorelin PhIII, and loses
Endpoints
Thu, 01/5/17 - 09:08 am
Aeterna Zentaris
macimorelin
clinical trials
growth hormone deficiency
Aeterna Zentaris reports 2Q loss
Yahoo/AP
Wed, 08/10/16 - 09:51 am
Aeterna Zentaris
earnings
Aeterna Zentaris posts 1st-quarter loss of $3.7 million
Yahoo/AP
Mon, 05/9/16 - 09:49 pm
Aeterna Zentaris
earnings
Aeterna Zentaris Announces At the Market Issuance Program
Yahoo
Sat, 04/2/16 - 01:59 pm
Aeterna Zentaris
market issuance
Top 6 BioPharma Movers of the Week
24/7 Wall St
Sat, 12/5/15 - 12:49 pm
Anavex
Aeterna Zentaris
Arena Pharmaceuticals
Foamix
Invivo Therapeutics
Zafgen
Aeterna Zentaris Rises on Finalized Marketing Agreement
24/7 Wall St
Tue, 12/1/15 - 01:04 pm
Aeterna Zentaris
Armune BioScience
Apifiny
prostate cancer
Aeterna Zentaris Announces Restructuring of Finance & Accounting Operations and Closure of Quebec City Office
Yahoo
Mon, 10/12/15 - 08:52 am
Aeterna Zentaris
restructuring
Aeterna Zentaris reports 2Q loss
Yahoo/AP
Thu, 08/13/15 - 06:22 pm
Aeterna Zentaris
earnings
Aeterna Zentaris: Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin in Prostate Cancer Published in Clinical Cancer Research
Yahoo
Mon, 12/29/14 - 09:34 am
Aeterna Zentaris
prostate cancer
zoptarelin doxorubicin
Aeterna Zentaris bottoms out after a stinging FDA rejection
Fierce Biotech
Fri, 11/7/14 - 10:15 am
Aeterna Zentaris
FDA
macimorelin
Aeterna Zentaris announces workforce reduction and optimization program
Yahoo/Fly on the Wall
Tue, 06/10/14 - 10:40 am
Aeterna Zentaris
layoffs
AEterna Zentaris: An Interesting Investment With Long-Term Growth Potential
Seeking Alpha
Tue, 08/20/13 - 11:58 am
Aeterna Zentaris
AEZS-130

Pages